Spectrum Pharmaceuticals is an American biopharmaceutical company. The company is located in Boston, MA. In April 2023, Assertio Holdings acquired Spectrum Pharmaceuticals in a deal worth $248M. Spectrum develops and markets drugs for treatments in hematology and oncology. In January 2019, Spectrum sold off its entire commercial portfolio of seven marketed hematology/oncology products to Acrotech Biopharma USA Inc., a New Jersey-based subsidiary of Aurobindo Pharma Limited in India. The seven products sold were Fusilev (levoleucovorin), Folotyn (pralatexate injection), Zevalin (ibritumomab tiuxetan), Marqibo (vincristine sulfate LIPOSOME injection), Beleodaq (belinostat) for injection, Evomela (melphalan) for injection, and Khapzory (levoleucovorin). More information...
According to PR-model, spectrumpharm.com is ranked 1,808,562nd in multilingual Wikipedia, in particular this website is ranked 202,299th in Japanese Wikipedia.
The website is placed before eastafricaholdings.com.et and after asiaeraone.com in the BestRef global ranking of the most important sources of Wikipedia.
